5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of 5-Amino-1MQ is not established in humans. This means dosing once to twice daily is typical to maintain stable levels. The half-life directly affects how long 5-Amino-1MQ remains active and influences optimal injection timing.
What Is the Half-Life of 5-Amino-1MQ?
The half-life of 5-Amino-1MQ is not established in humans. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer 5-Amino-1MQ to maintain therapeutic blood levels.
What Does 5-Amino-1MQ's Half-Life Mean for Dosing?
With a half-life of not established in humans, 5-Amino-1MQ requires dosing once to twice daily to maintain stable levels. The standard dosage of 150-500 mcg subcutaneous, 50-100 mg oral via subcutaneous injection or oral accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, 5-Amino-1MQ reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For 5-Amino-1MQ, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject 5-Amino-1MQ?
Optimal timing depends on your research goals. A half-life of not established in humans means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once to twice daily) for more stable levels throughout the day.
How Does 5-Amino-1MQ's Half-Life Compare to Similar Peptides?
5-Amino-1MQ is a Small molecule NNMT inhibitor. Its half-life of not established in humans positions it with a longer duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your 5-Amino-1MQ Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 5-Amino-1MQ.
Open Calculator →Bottom Line: 5-Amino-1MQ Half-Life and Dosing
5-Amino-1MQ has a half-life of not established in humans, supporting the standard protocol of 150-500 mcg subcutaneous, 50-100 mg oral dosed once to twice daily over 4-12 weeks.
Read our 5-Amino-1MQ dosage guide for complete protocol details.
Complete Guide
5-Amino-1MQ : Benefits, Dosage, Side Effects & Research
Related Reading
- 5-Amino-1MQ Dosage Guide
- 5-Amino-1MQ Benefits
- 5-Amino-1MQ Side Effects
- 5-Amino-1MQ Stacking Guide
- 5-Amino-1MQ Cycle Guide
- 5-Amino-1MQ Research
Research-Grade Sourcing
If you're going to research 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What is the recommended 5-Amino-1MQ dosage?
Common dosages: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Cycle length: 4-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Is 5-Amino-1MQ safe?
5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.